Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells.
COVID-19 vaccines based on the Spike protein of SARS-CoV-2 have been developed that appear to be largely successful in stopping infection. However, therapeutics that can help manage the disease are still required until immunity has been achieved globally. The identification of repurposed drugs that...
Saved in:
| Main Authors: | Adam Pickard, Ben C Calverley, Joan Chang, Richa Garva, Sara Gago, Yinhui Lu, Karl E Kadler |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-09-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009840&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
“Outlaw” mutations in quasispecies of SARS-CoV-2 inhibit replication
by: Philippe Colson, et al.
Published: (2024-12-01) -
The Slow Pandemic: Emergence of Antimicrobial Resistance in the Postadvent of SARS-CoV-2 Pandemic
by: Ayodeji Osunla, et al.
Published: (2025-01-01) -
Replication fork slowing and stalling are distinct, checkpoint-independent consequences of replicating damaged DNA.
by: Divya Ramalingam Iyer, et al.
Published: (2017-08-01) -
Inhibitory activity of tea compositions and their constituent ingredients on SARS‐COV‐2 replication in vitro
by: Е. I. Каzachinskaia, et al.
Published: (2022-07-01) -
Replication differences of SARS-CoV-2 lineages may arise from unique RNA replication characteristics and nucleocapsid protein expression
by: Isadora Alonso Corrêa, et al.
Published: (2025-07-01)